WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with lipid-based transfection reagents

• Published in: Journal of nanobiotechnology Vol. 19; no. 1; p. 236
• Main Authors: Konate, Karidia, Josse, Emilie, Tasic, Milana, Redjatti, Karima, Aldrian, Gudrun, Deshayes, Sébastien, Boisguérin, Prisca, Vivès, Eric
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 11-08-2021; BioMed Central; BMC
• Subjects: Amino acid composition; Amino Acid Sequence; Amino acids; Analysis; Cell Line, Tumor; Cell-Penetrating Peptides; Chemical properties; Composition; Compression Bandages; Drug Delivery Systems; Drugs; Gene silencing; Gene Silencing - drug effects; Glioblastoma; Health aspects; Humans; Indicators and Reagents - chemistry; Internalization; Investigations; Leucine; Life Sciences; Lipids; Lipids - chemistry; Methods; Nanoparticle; Nanoparticles; Nanoparticles - chemistry; Peptides; Plasmids; Proline; Reagents; Residues; RNA, Small Interfering - chemistry; RNA, Small Interfering - pharmacology; siRNA; siRNA delivery; Structure-Activity Relationship; Structure-activity relationship (Pharmacology); Structure-activity relationships; Toxicity; Transfection; Tryptophan; France; siRNA delivery; Cell-penetrating peptides; Nanoparticle; Structure–activity relationship
• DOI: 10.1186/s12951-021-00972-8
• EISSN: 1477-3155

Recently, we designed novel amphipathic cell-penetrating peptides, called WRAP, able to transfer efficiently siRNA molecules into cells. In order to gain more information about the relationship between amino acid composition, nanoparticle formation and cellular internalization of these peptides composed of only three amino acids (leucine, arginine and tryptophan), we performed a structure-activity relationship (SAR) study. First, we compared our WRAP1 and WRAP5 peptides with the C6M1 peptide also composed of the same three amino acids and showing similar behaviors in siRNA transfection. Afterwards, to further define the main determinants in the WRAP activity, we synthesized 13 new WRAP analogues harboring different modifications like the number and location of leucine and arginine residues, the relative location of tryptophan residues, as well as the role of the α-helix formation upon proline insertions within the native WRAP sequence. After having compared the ability of these peptides to form peptide-based nanoparticles (PBNs) using different biophysical methods and to induce a targeted gene silencing in cells, we established the main sequential requirements of the amino acid composition of the WRAP peptide. In addition, upon measuring the WRAP-based siRNA transfection ability into cells compared to several non-peptide transfection agents available on the markets, we confirmed that WRAP peptides induced an equivalent level of targeted gene silencing but in most of the cases with lower cell toxicity as clearly shown in clonogenic assays.